3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?

about

Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment.

P2860

Q49358494-54D50D57-B04B-4F3B-B1AD-D9375A4844C6 Q50078388-9C4A4788-3045-4C71-8487-2D7B224E7C3B

P2860

3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?

Item

http://www.wikidata.org/entity/Q44297450

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@en

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@nl

type

Item

label

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@en

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@nl

prefLabel

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@en

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@nl

P1476

3D tissue-engineered bone marr ...... treatment of multiple myeloma?

@en

P2093

Abdel Kareem Azab

http://www.w3.org/2001/XMLSchema#string

Pilar de la Puente

http://www.w3.org/2001/XMLSchema#string

P2860

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Multiple myeloma.

Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.

P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.

The stem cell niche in health and malignancy.

P304

1545-1547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/FON-2016-0057

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27333447

http://www.w3.org/2001/XMLSchema#string

3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?

about

P2860

P2860

3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698